ES8504773A2 - Mejoras introducidas en el objeto de la patente principal n 513.469, por: procedimiento para preparar derivados de pirimidona
- Google Patents
Mejoras introducidas en el objeto de la patente principal n 513.469, por: procedimiento para preparar derivados de pirimidona
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories LtdfiledCriticalSmith Kline and French Laboratories Ltd
Priority to ES529046ApriorityCriticalpatent/ES529046A0/es
Publication of ES8504773A2publicationCriticalpatent/ES8504773A2/es
Publication of ES529046A0publicationCriticalpatent/ES529046A0/es
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
PROCEDIMIENTO PARA PREPARAR DERIVADOS DE PIRIMIDONA. MEJORA LA PATENTE PRINCIPAL NUM. 513.469.CONSISTE EN HACER REACCIONAR UNA GUANIDINA DE FORMULA (II) CON UN COMPUESTO DE FORMULA (III) PARA OBTENER COMPUESTOS DE FORMULA (I), DONDE R ES HALOGENO O NITRO; R ES ALQUILO C 1 A 4; R ES UN GRUPO ALQUILENO C 1 A 3; R ES 3-PIRIDILO, N-OXO-3-PIRIDILO, 6-METIL-3-PIRIDILO Y OTROS; Y R ES ALQUILO CON C 1 A 4, BENCILO O FENILO.SE UTILIZAN COMO ANTAGONISTAS DE HISTAMINA H1.
ES529046A1984-01-201984-01-20Mejoras introducidas en el objeto de la patente principal n 513.469, por: procedimiento para preparar derivados de pirimidona
GrantedES529046A0
(es)
Composto, composição farmacêutica, uso de um composto, e, processos para tratar ou reduzir o risco de doenças ou condições humanas, o risco de doença inflamatória o risco da dor e para a preparação de um composto